Ageing: from inflammation to cancer
Giulia C. Leonardi(Harvard University), Massimo Libra(University of Catania), Giulia Accardi(University of Palermo), Roberto Monastero(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Ferdinando Nicoletti(University of Catania)
Cited by 241
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
|Frontiers in Pharmacology|2018|878
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508